| scholarly article | Q13442814 |
| P50 | author | Mauricio P. Cunha | Q41090858 |
| Ana Lúcia S Rodrigues | Q41090877 | ||
| Vicente Lieberknecht | Q41630648 | ||
| P2093 | author name string | André R S Colla | |
| Julia M Rosa | |||
| Francis L Pazini | |||
| Ágatha Oliveira | |||
| P2860 | cites work | Hippocampal atrophy in recurrent major depression | Q24598190 |
| mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade | Q24617166 | ||
| mTOR signaling: at the crossroads of plasticity, memory and disease | Q24647655 | ||
| Increasing Adult Hippocampal Neurogenesis is Sufficient to Reduce Anxiety and Depression-Like Behaviors | Q27310639 | ||
| The phosphoinositide 3-kinase pathway | Q27860738 | ||
| Phosphatidylinositol 3-kinase activation is required for stress protocol-induced modification of hippocampal synaptic plasticity | Q28259863 | ||
| The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
| A simplification of the protein assay method of Lowry et al. which is more generally applicable | Q29615220 | ||
| Antidepressant effects of ketamine in depressed patients | Q29617327 | ||
| A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression | Q29617914 | ||
| mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists | Q29618120 | ||
| Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses | Q29618915 | ||
| Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling | Q33620621 | ||
| Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex | Q33925307 | ||
| Medication augmentation after the failure of SSRIs for depression. | Q33994373 | ||
| In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function | Q34200391 | ||
| A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder | Q34292341 | ||
| Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure | Q34744471 | ||
| Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone | Q34806426 | ||
| The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder | Q35159668 | ||
| Signaling pathways underlying the rapid antidepressant actions of ketamine | Q35375293 | ||
| Ketamine as a promising prototype for a new generation of rapid-acting antidepressants | Q35547495 | ||
| Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents | Q35754079 | ||
| Chronic glucocorticoids increase hippocampal vulnerability to neurotoxicity under conditions that produce CA3 dendritic retraction but fail to impair spatial recognition memory | Q36008063 | ||
| Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study | Q36271087 | ||
| Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress | Q36460302 | ||
| Brain-derived neurotrophic factor and suicide pathogenesis | Q37003649 | ||
| Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone | Q37079545 | ||
| Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression | Q37128042 | ||
| Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. | Q37380865 | ||
| Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner. | Q37480270 | ||
| Antidepressant-like effect of creatine in mice involves dopaminergic activation. | Q48666146 | ||
| Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration. | Q48819465 | ||
| Sex and the suffering brain | Q48860544 | ||
| Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats | Q48908051 | ||
| Effects of l-arginine and creatine administration on spatial memory in rats subjected to a chronic variable stress model. | Q50680134 | ||
| Effect of perinatal lead exposure on rat behaviour in open-field and two-way avoidance tasks. | Q52200061 | ||
| Involvement of PI3K, GSK-3β and PPARγ in the antidepressant-like effect of folic acid in the forced swimming test in mice | Q60688896 | ||
| The tail suspension test: a new method for screening antidepressants in mice | Q69947780 | ||
| Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety | Q83805724 | ||
| Accelerating response to antidepressant treatment in depression: a review and clinical suggestions | Q37647040 | ||
| Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression | Q37708545 | ||
| Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression | Q37798043 | ||
| Investigational NMDA receptor modulators for depression | Q37957965 | ||
| Intravenous ketamine for treatment-resistant major depressive disorder. | Q37970647 | ||
| A review of Atypical depression in relation to the course of depression and changes in HPA axis organization | Q38002165 | ||
| Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: Involvement of intracellular signaling pathways. | Q39181634 | ||
| The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects | Q40849137 | ||
| Modulation of the suppressive effect of corticosterone on adult rat hippocampal cell proliferation by paroxetine. | Q41333350 | ||
| The modulation of NMDA receptors and L-arginine/nitric oxide pathway is implicated in the anti-immobility effect of creatine in the tail suspension test. | Q41630586 | ||
| Recapitulation and reversal of a persistent depression-like syndrome in rodents | Q42092713 | ||
| Corticosterone reduces dendritic complexity in developing hippocampal CA1 neurons. | Q42449829 | ||
| Neuroscience. A glutamate pathway to faster-acting antidepressants? | Q42931853 | ||
| Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain | Q43153875 | ||
| Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model | Q43184352 | ||
| Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment | Q44095451 | ||
| Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary-adrenal axis in rhesus monkeys | Q44870147 | ||
| Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. | Q44978632 | ||
| A pilot dose-finding clinical trial of creatine monohydrate augmentation to SSRIs/SNRIs/NASA antidepressant treatment in major depression | Q45331177 | ||
| Acute atorvastatin treatment exerts antidepressant-like effect in mice via the L-arginine-nitric oxide-cyclic guanosine monophosphate pathway and increases BDNF levels | Q45838943 | ||
| Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat. | Q45978058 | ||
| The varying effects of short-term and long-term corticosterone injections on depression-like behavior in mice. | Q46033158 | ||
| Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients. | Q46182606 | ||
| Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression. | Q46363954 | ||
| Comparison of the effects of clonidine and ketamine added to ropivacaine on stress hormone levels and the duration of caudal analgesia | Q46550556 | ||
| A mouse model of depression induced by repeated corticosterone injections | Q46815898 | ||
| Creatine monohydrate in resistant depression: a preliminary study | Q46910762 | ||
| Effect of subanaesthetic ketamine on plasma and saliva cortisol secretion | Q47703710 | ||
| The activation of α1-adrenoceptors is implicated in the antidepressant-like effect of creatine in the tail suspension test. | Q47920566 | ||
| Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex | Q47939452 | ||
| Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways. | Q47978385 | ||
| Involvement of PI3K/Akt Signaling Pathway and Its Downstream Intracellular Targets in the Antidepressant-Like Effect of Creatine. | Q48083788 | ||
| Effect of antidepressants on brain-derived neurotrophic factor (BDNF) release from platelets in the rats | Q48090906 | ||
| Depressive-like behavior induced by tumor necrosis factor-α in mice. | Q48115613 | ||
| Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice. | Q48191591 | ||
| Evidence for the involvement of 5-HT1A receptor in the acute antidepressant-like effect of creatine in mice | Q48192922 | ||
| Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder | Q48203760 | ||
| Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms | Q48278968 | ||
| Hypercortisolemia and hippocampal changes in depression | Q48294921 | ||
| Piperine reverses the effects of corticosterone on behavior and hippocampal BDNF expression in mice | Q48296943 | ||
| Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. | Q48459505 | ||
| Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. | Q48479293 | ||
| Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women | Q48561639 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 6818-6834 | |
| P577 | publication date | 2015-12-11 | |
| P1433 | published in | Molecular Neurobiology | Q15716645 |
| P1476 | title | Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway | |
| P478 | volume | 53 |
| Q92392721 | Abnormal expression of rno_circRNA_014900 and rno_circRNA_005442 induced by ketamine in the rat hippocampus |
| Q89998378 | Chlorogenic acid protects PC12 cells against corticosterone-induced neurotoxicity related to inhibition of autophagy and apoptosis |
| Q47558662 | Chronic dietary creatine enhances hippocampal-dependent spatial memory, bioenergetics, and levels of plasticity-related proteins associated with NF-κB. |
| Q89620192 | Cortisol and Major Depressive Disorder-Translating Findings From Humans to Animal Models and Back |
| Q48039679 | Creatine Prevents Corticosterone-Induced Reduction in Hippocampal Proliferation and Differentiation: Possible Implication for Its Antidepressant Effect |
| Q97540341 | Creatine and taurine mixtures alleviate depressive-like behaviour in Drosophila melanogaster and mice via regulating Akt and ERK/BDNF pathways |
| Q92876206 | Creatine for the Treatment of Depression |
| Q89747533 | Dietary creatine intake and depression risk among U.S. adults |
| Q47831328 | Glutamatergic system and mTOR-signaling pathway participate in the antidepressant-like effect of inosine in the tail suspension test. |
| Q55089313 | Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide. |
| Q99201902 | Ketamine, but not guanosine, as a prophylactic agent against corticosterone-induced depressive-like behavior: Possible role of long-lasting pro-synaptogenic signaling pathway |
| Q93087807 | Low-Frequency Pulsed Magnetic Field Improves Depression-Like Behaviors and Cognitive Impairments in Depressive Rats Mainly via Modulating Synaptic Function |
| Q60951344 | Mechanisms and Therapeutic Targets of Depression After Intracerebral Hemorrhage |
| Q64235454 | Mechanisms of Aerobic Exercise Upregulating the Expression of Hippocampal Synaptic Plasticity-Associated Proteins in Diabetic Rats |
| Q92512363 | Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function |
| Q95643364 | Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators |
| Q47874568 | Single Administration of HBK-15-a Triple 5-HT1A, 5-HT7, and 5-HT3 Receptor Antagonist-Reverses Depressive-Like Behaviors in Mouse Model of Depression Induced by Corticosterone. |
| Q92204594 | The cerebellum under stress |
| Q47742617 | The requirement of L-type voltage-dependent calcium channel (L-VDCC) in the rapid-acting antidepressant-like effects of scopolamine in mice |
| Q41109428 | miR-16 and Fluoxetine Both Reverse Autophagic and Apoptotic Change in Chronic Unpredictable Mild Stress Model Rats |
Search more.